HHG GROUP
Language
Direction Contact us
Mitera MENU
Plomaritoglou Androniki

Plomaritoglou Androniki Phychiatrist Neurologist

Assistant Director, Neurology Department ΗYGEIA Hospital

Education & Academic Qualifications

  • Medicine Diploma -Athens University Medical School
  • Specialty of Neurology at Eginition Hospital-Athens University Medical School
  • Sub specialty in Cerebrovascular diseases-Stroke at Massachusetts General Hospital, Harvard University Medical School
  • Masters degree in Epidemiology at Harvard School of Public Health
  • Neurovascular Ultrasound, Wake Forest University School of Medicine

Scholarships:

  • Hellenic Harvard Foundation
  • Gerondelis Foundation
  • Th. & Th. Cozzika Public Benefit Foundation
  • A.S.Onassis Public Benefit Foundation

 

Doctoral thesis

  • “Fever in Patients with Acute Stroke” Athens University Medical School

Fellowship in Societies, Membership in Journal Editorial Committees

  • Greek Neurological Association

  • International Society of Greek Neuroscientists

  • American Academy of Neurology

  • American Heart Association/American stroke Association

  • Hellenic Stroke Organization

  • European Stroke Organization

 

Work Experience

  • Consultant Neurologist at Hygeia Hospital

  • Deputy Director of Neurology Clinic

  • Outpatient clinic-Private Practice

Research – Education Experience

  • Clinical investigator in several international clinical trials (GAIN study, etc.) during the fellowship period in Cerebrovascular diseases – Stroke at Harvard University

  • Clinical adjudicator in international clinical trials: CHARISMA, and CRESCENDO trials

  • Teaching courses at educational seminars of Hellenic Stroke Organization 

  • Teaching courses at educational seminars of postgraduate doctors at Hygeia Hospi-tal, Athens, Greece.

  • Teaching courses at educational seminars of neurologists at Public General hospital “G. Gennimatas”, Athens, Greece

  • Teaching courses at educational seminars in Neurology, at Navy Hospital, Athens, Greece

  • Teaching courses in APLS (Advanced Pediatric Life Support) seminar, organized by the 1st University Pediatric clinic, “St Sophia” Childrens’ Hospital” Athens, Greece

 

Clinical & Research Interest

Clinical Interest:

  • Stroke, Cerebral Amyloid Angiopathy, CNS Vasculitis

  • Multiple Sclerosis 

  • Limbic Encephalitis, autoimmune, paraneoplastic

  • Cerebellar Syndromes

  • Dementia, Vascular, Frontotemporal

  • Parkinson’s disease

  • Headache

Research Interest:

  • Stroke, Cerebral Amyloid Angiopathy, CNS Vasculitis

  • Multiple Sclerosis 

  • Limbic Encephalitis, autoimmune, paraneoplastic

  • Cerebellar Syndromes

  • Dementia, Vascular, Frontotemporal

  • Headache

 

Books

  • Seth P. Finklestein and Androniki Plomaritoglou. “Growth Factors”. In L. Miller, ed., Head Trauma: Basic, Preclinical, and Clinical Aspects, John Wiley and Sons, Inc, New York.

  • Plomari-toglou A, Georgilis K. “Encephalitis” in K. Georgilis, V. Seitanidis ed. Emergencies in Infectious disease Medicine, ZITA editions, Athens, Greece. 2003.

  • Plomari-toglou A, “Cerebrovascular disease – Stroke”. In “Update in Internal Medicine: new developments in diagnosis and treatment in Internal Medicine”. Hygeia Hos-pital editions, Atnens, Greece, 2006.

  • Plomari-toglou A, “Cerebrovascular disease – Stroke”. In “Update in Internal Medicine: new developments in diagnosis and treatment in Internal Medicine”. Hygeia Hos-pital editions, Atnens, Greece, 2011.

 

Recent Publications

  • Georgilis K, Plomaritoglou A, Dafni U, Bassiakos Y, Vemmos K. Etiology of fever in patients with acute stroke. Journal of Internal Medicine (1999 Aug; 246(2):203-9).(Impact Factor:2.382)

  • Athanasoulis CA, Plomaritoglou A. Preoperative imaging of the carotid bifurcation. Current trends. Int Angiol (2000 Mar;19(1):1-7).(Impact Factor:0.465)

  • Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveira S, Plomaritoglou A, Furie KL.Homocysteine, MTHFR 677C–>T polymorphism, and risk of ischemic stroke: re-sults of a meta-analysis. Neurology (2002 Aug 27;59(4):529-36). (Impact Factor:4.633)